Spread of Multidrug-Resistant Pseudomonas aeruginosa Clones in a University Hospital

被引：37

作者：

Koutsogiannou, Maria ^{[1
]}

Drougka, Eleanna ^{[1
]}

Liakopoulos, Apostolos ^{[2
]}

Jelastopulu, Eleni ^{[3
]}

Petinaki, Efthimia ^{[2
]}

Anastassiou, Evangelos D. ^{[1
]}

Spiliopoulou, Iris ^{[1
]}

Christofidou, Myrto ^{[1
]}

机构：

[1] Univ Patras, Sch Med, Dept Microbiol, GR-26110 Patras, Greece

[2] Univ Thessalia, Sch Med, Dept Microbiol, Larisa, Greece

[3] Univ Patras, Sch Med, Dept Publ Hlth, GR-26110 Patras, Greece

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2013年 / 51卷 / 02期

关键词：

METALLO-BETA-LACTAMASE; OUTBREAK; INFECTIONS; VIM-2; SECRETION; VIRULENCE; STRAINS; CROATIA; TOXINS; GENE;

D O I：

10.1128/JCM.03071-12

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

An outbreak of multidrug-resistant Pseudomonas aeruginosa (MDRPA) infections in a university hospital is described. Phenotypic and genotypic analysis of 240 isolates revealed that 152 patients, mainly in the intensive care unit (ICU), were colonized or infected with MDRPA, the majority with O11. All metallo-beta-lactamase (MBL)-positive isolates carried the bla(VIM-2) or bla(VIM-1) gene. One or more type III secretion system toxin genes were detected in most isolates. Five dominant pulsed-field gel electrophoresis (PFGE) types were characterized, associated with ST235, ST111, ST253, ST309, and ST639.

引用

页码：665 / 668

页数：4

共 50 条

[21] RISK FACTORS AND OUTCOMES OF HOSPITAL ACQUIRED PNEUMONIA CAUSED BY MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA
Feng, Ding Yun
Zou, Xiaoling
Yang, Hailing
Li, Wenjuan
Zhou, Yuqi
Zhang, Tiantuo
RESPIROLOGY, 2017, 22 : 270 - 271
[22] Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan
Leung, Ching-Hsiang
Wang, Nai-Yu
Liu, Chang-Pan
Weng, Li-Chuan
Hsieh, Feng-Chih
Lee, Chun-Ming
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2008, 41 (06) : 491 - 498
[23] Salvage Therapy with CeftolozaneTazobactam for Multidrug-Resistant Pseudomonas aeruginosa Infections
Jose Caston, Juan
De la Torre, Alvaro
Ruiz-Camps, Isabel
Luisa Sorli, Maria
Torres, Vicente
Torre-Cisneros, Julian
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (03)
[24] Synergy of drug combinations in treating multidrug-resistant Pseudomonas aeruginosa
Rizvi, Meher
Ahmad, Junaid
Khan, Fatima
Shukla, Indu
Malik, Abida
Sami, Hiba
AUSTRALASIAN MEDICAL JOURNAL, 2015, 8 (01): : 1 - 6
[25] Outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit
Durojaiye, O. C.
Carbarns, N.
Murray, S.
Majumdar, S.
JOURNAL OF HOSPITAL INFECTION, 2011, 78 (02) : 154 - 155
[26] Carbapenem-resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa
Fuste, Ester
Lopez-Jimenez, Lidia
Segura, Concha
Gainza, Eusebio
Vinuesa, Teresa
Vinas, Miguel
JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 62 : 1317 - 1325
[27] Antimicrobial effects of drugs against multidrug-resistant Pseudomonas aeruginosa
Maeda, Kumiko
Kobayashi, Youko
Oie, Shigeharu
Ishida, Shiro
Okano, Yoshiro
Kobayashi, Toshihiko
Shikichi, Kyoko
Mizuno, Hidekazu
Kamiya, Akira
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (10) : 1898 - 1901
[28] Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa
Giamarellos-Bourboulis, EJ
Kentepozidis, N
Antonopoulou, A
Plachouras, D
Tsaganos, T
Giamarellou, H
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 51 (02) : 113 - 117
[29] Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact
Aloush, V
Navon-Venezia, S
Seigman-Igra, Y
Cabili, S
Carmeli, Y
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) : 43 - 48
[30] ABDOMINAL COLISTIN IRRIGATION FOR MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA INFECTION
Amer, Marwa
Alghunaim, Razan
Almaghrabi, Reem
CRITICAL CARE MEDICINE, 2020, 48

← 1 2 3 4 5 →